Bliss GVS Pharma Ltd. | Income Statement
Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
Sales/Revenue
3,397
4,031
5,367
3,772
3,638
Cost of Goods Sold (COGS) incl. D&A
2,105
2,280
3,098
2,425
2,395
Gross Income
1,292
1,751
2,270
1,347
1,243
SG&A Expense
708
849
925
660
415
Unusual Expense
1
-
-
-
-
Non Operating Income/Expense
287
188
270
274
133
Interest Expense
180
164
182
132
86
Pretax Income
706
960
1,482
879
640
Income Tax
295
346
480
364
323
Consolidated Net Income
410
614
1,001
515
317
Net Income
410
599
825
509
297
Net Income After Extraordinaries
410
599
825
197
7
Net Income Available to Common
410
599
825
820
588
EPS (Basic)
3.97
5.81
8.00
7.95
5.70
Basic Shares Outstanding
103
103
103
103
103
EPS (Diluted)
3.97
5.81
8.00
7.95
5.70
Diluted Shares Outstanding
103
103
103
103
103
EBITDA
663
994
1,457
782
903
Other Operating Expense
28
21
20
12
16
Non-Operating Interest Income
41
55
69
62
47
Minority Interest Expense
-
15
177
7
20
About Bliss GVS Pharma
View Profile
